Case Study: Neuren Pharmaceuticals achieves a complete eQMS implementation in 12 weeks with Egnyte

Neuren Pharmaceuticals Implements Egnyte as eQMS in Record Time

Neuren Pharmaceuticals needed to implement a new, compliant electronic Quality Management System (eQMS) while also replacing its legacy quality documentation, all without overrunning timelines or budget. The company evaluated several vendors and chose Egnyte’s life sciences solution for its 21 CFR Part 11 compliance, ease of use, and cost-effectiveness.

Egnyte helped Neuren Pharmaceuticals go live with a complete eQMS in just 12 weeks, far faster than the industry norm of six months or more. The implementation included multiple domains for testing, validated GxP work, and non-GxP collaboration, and led to nearly 100% training compliance within six weeks while also reducing validation costs and expanding use into CAPA, deviations, audits, and change control.

Neuren Pharmaceuticals

Sharon Reinhard

Pharmaceutical Executive